FOR IMMEDIATE RELEASE
New Probiotic Oral Care Product, EvoraPlus, Selected to be Distributed by drugstore.com
The Florida-based biotechnology firm Oragenics, Inc. partners with leading online retailer to distribute its groundbreaking oral care product
ALACHUA, FL (February 2, 2009) – The Florida-based biotechnology firm Oragenics, Inc. (Symbol: ORNI) announces that its revolutionary new probiotic mint, EvoraPlus, has been selected by drugstore.com to be one of its featured products. drugstore.com is a leading online retailer of health, beauty and wellness products, shipping to more than 35 countries worldwide. “We’re delighted to launch this next generation of proactive oral care,” said Sandee Escene, category manager at drugstore.com. “Our customers appreciate innovative products like EvoraPlus. It’s an ideal fit for drugstore.com’s wide selection.” EvoraPlus is a revolutionary new application of probiotics, which have traditionally been used to support digestive and immune health. EvoraPlus is the first probiotics product specifically designed for complete oral care. This all-inone product supports gum and tooth health and naturally freshens breath while gently whitening teeth. EvoraPlus was developed by Dr. Jeffrey Hillman, D.M.D., Ph.D., and Chief Scientific Officer at Oragenics. It’s the result of more than 25 years of research,
which began at the Harvard-affiliated Forsyth Institute in Boston and continued at the University of Florida. The technology has only recently become available for the general public. “With more than a million consumers visiting drugstore.com on a weekly basis, we’re delighted to have our innovative new product available to their health and wellness customers,” says Stanley Stein, Oragenics’ CEO. “We’re proud to partner with such a forward-thinking company.” To schedule an interview with Stanley Stein, contact Linda Loren at 727456-0029; lloren@onibiopharma.com.
About Oragenics Oragenics, Inc. is a biopharmaceutical company engaged in developing unique proprietary technologies, some of which are being commercialized and sold in the over-the-counter consumer healthcare market. The company also has a number of products in discovery, preclinical and clinical development, with a concentration in the main therapeutic area of infectious diseases, diagnostics, and oral health. The company is located in Progress Corporate Park at 13700 Progress Boulevard in Alachua, Florida, approximately 15 miles from the campus of the University of Florida in Gainesville.
CONTACT: Linda Loren, Marketing Director Oragenics, Inc. 727-456-0029 lloren@onibiopharma.com